Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus

Go back to Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus
(NASDAQ: APYX) Delayed: 4.11 -0.1 (2.38%)
Previous Close $4.21    52 Week High
Open $4.17    52 Week Low
Day High $4.24    P/E N/A 
Day Low $4.01    EPS
Volume 194,791